Package 13668-581-60

{"route": ["ORAL"], "spl_id": "1f85153f-5d3a-40d8-8570-1d969f4efa3c", "openfda": {"nui": ["N0000175599", "N0000020026"], "upc": ["0313668581300"], "unii": ["742SXX0ICT"], "rxcui": ["2123194"], "spl_set_id": ["88132351-7fee-47ef-8007-ef2777543299"], "pharm_class_epc": ["Phosphodiesterase 5 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 5 Inhibitors [MoA]"], "manufacturer_name": ["Torrent Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (13668-581-30)", "package_ndc": "13668-581-30", "marketing_start_date": "20190326"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (13668-581-60)", "package_ndc": "13668-581-60", "marketing_start_date": "20201121"}], "brand_name": "TADALAFIL", "product_id": "13668-581_1f85153f-5d3a-40d8-8570-1d969f4efa3c", "dosage_form": "TABLET", "pharm_class": ["Phosphodiesterase 5 Inhibitor [EPC]", "Phosphodiesterase 5 Inhibitors [MoA]"], "product_ndc": "13668-581", "generic_name": "TADALAFIL", "labeler_name": "Torrent Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TADALAFIL", "active_ingredients": [{"name": "TADALAFIL", "strength": "20 mg/1"}], "application_number": "ANDA212062", "marketing_category": "ANDA", "marketing_start_date": "20190326", "listing_expiration_date": "20271231"}